Affyimmune Therapeutics Is A Clinical Stage Biotechnology Company Based In Natickmassachusettsfounded In 2016The Company Is Dedicated To Developing Advanced Car T Cell Therapies Specifically For Solid Tumorsfocusing On Cancers Characterized By The Overexpression Of Icam 1Affyimmune Aims To Meet Significant Unmet Medical Needs In Oncology Through Its Innovative Technologies The Company Specializes In Optimizing Car T Cells To Enhance Their Targeting And Destruction Of Tumor Cells While Protecting Healthy Tissueskey Technologies Include Affinity Tuningwhich Adjusts The Binding Strength Of Car T Cells To Selectively Target Cancer Cellsand Noninvasive Monitoringallowing Real Time Tracking Of Car T Cells In Patientsaffyimmune S Lead Candidateaic100Is An Icam 1 Directed Car T Therapy Currently In Clinical Trialswith Designations From The Fda That Expedite Its Development For Anaplastic And Advanced Differentiated Thyroid Cancersas Well As Non Small Cell Lung Cancer
No conferences found for this company.
| Company Name | Affyimmune Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
